Toremifene
Back to searchMolecule Structure
Scientific Name
Toremifene
Description of the Drug
Toremifene is a first generation nonsteroidal selective estrogen receptor modulator used to treat certain breast cancers.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-02-07 from
http://www.drugbank.ca/drugs/DB00539
http://www.drugbank.ca/drugs/DB00539
Brand Name(s)
Not Available
Company Owner(s)
Msn Laboratories Private Ltd, Rising Pharma Holdings Inc, Kyowa Kirin Inc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Estrogen receptor | PROTEIN FAMILY | MODULATOR | CHEMBL2093866 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL7465 | ||
| PharmGKB | PA451731 | ||
| Human Metabolome Database | HMDB0014679 | ||
| DrugBank | DB00539 | ||
| PubChem: Thomson Pharma | 14757386 | ||
| PubChem | 3005573 | ||
| LINCS | LSM-42973 | ||
| Nikkaji | J745.747B | J33.157K | |
| PDBe | T0R | ||
| BindingDB | 58492 | ||
| EPA CompTox Dashboard | DTXSID3023689 | ||
| DrugCentral | 2709 | ||
| ChemicalBook | CB0287854 | ||
| Guide to Pharmacology | 4325 | ||
| GSRS | 87780425-c47d-494c-bc45-3c4715aaa5de | ||
| rxnorm | TOREMIFENE | FARESTON | TOREMIFENE CITRATE |
| PubChem: Drugs of the Future | 12013627 | ||
| KEGG Ligand | C08166 | ||
| ChEBI | 9635 | ||
| ZINC | ZINC000012404516 |
